BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18090213)

  • 1. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
    Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
    Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
    Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies.
    Le Jeune FP; Dubois F; Blond S; Steinling M
    J Neurooncol; 2006 Apr; 77(2):177-83. PubMed ID: 16314957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
    Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
    J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
    Beauchesne P; Pedeux R; Boniol M; Soler C
    J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H; Riad R; Omar W; Zaher A; Ebied E
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography to detect recurrent or residual nasopharyngeal carcinomas after radiotherapy.
    Shiau YC; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2001; 21(3C):2213-7. PubMed ID: 11501849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of 99mTc-MIBI brain spect (functional index ratios) and survival after treatment failure in malignant glioma patients.
    Beauchesne P; Soler C
    Anticancer Res; 2002; 22(5):3081-5. PubMed ID: 12530047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
    Fan YX; Luo RC; Li GP; Zheng H; Huang K
    Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.
    Soler C; Beauchesne P; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
    Eur J Nucl Med; 1998 Dec; 25(12):1649-57. PubMed ID: 9871097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of examination affects reliability of 99mTc-methoxyisobutylisonitrile SPECT in distinguishing neoplastic from nonneoplastic brain hematomas.
    Minutoli F; Angileri FF; Conti A; Herberg A; Aricò D; Baldari S; Cardali S; de Divitiis O; Germanò A; Baldari S
    J Nucl Med; 2005 Apr; 46(4):574-9. PubMed ID: 15809478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
    Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
    Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
    Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is cerebral tomoscintigraphy with 99mTc-MIBI useful in the diagnosis of local recurrence in patients with malignant gliomas?].
    Beauchesne P; Soler C; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
    Cancer Radiother; 1998; 2(1):42-8. PubMed ID: 9749095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.
    Furuta M; Nozaki M; Kawashima M; Iimuro M; Kitazumi Y; Okayama A; Natsui S; Hamashima Y; Nagao K
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):982-7. PubMed ID: 12734691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-negative Tc-99m MIBI scintigraphy in histopathologically proved recurrent high-grade oligodendroglioma.
    Goethals I; De Winter O; Dierckx R; Annovazzi A; Signore A; van de Wiele C
    Clin Nucl Med; 2003 Apr; 28(4):299-301. PubMed ID: 12642708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
    Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
    J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.